Media coverage
1
Media coverage
Title Re-Vana Therapeutics Strengthens Executive Team Degree of recognition International Media name/outlet Businesswire Media type Web Country/Territory United Kingdom Date 23/02/2021 Description Re-Vana Therapeutics Strengthens Executive Team with the Appointments of Michael Nash as Chief Commercial Officer and David Shima, PhD, as Vice President of R&D New Appointments Bring Extensive Ocular Drug Delivery, Strategy and Scientific Expertise to Advance the Sustained Release of Biologics and Small Molecules into the Eye to Treat Sight-Threatening Eye Diseases Producer/Author ReVana URL https://www.businesswire.com/news/home/20210223005101/en/Re-Vana-Therapeutics-Strengthens-Executive-Team-with-the-Appointments-of-Michael-Nash-as-Chief-Commercial-Officer-and-David-Shima-PhD-as-Vice-President-of-RD Persons Thakur Raghu Raj Singh